UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $12.44 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 22.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 313,709 shares of the company's stock after buying an additional 56,647 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.34% of Acadia Healthcare worth $12,439,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ACHC. Lindbrook Capital LLC lifted its holdings in shares of Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after purchasing an additional 671 shares during the period. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the period. Nisa Investment Advisors LLC lifted its holdings in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares during the period. Signaturefd LLC lifted its holdings in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after purchasing an additional 1,004 shares during the period. Finally, Fifth Third Bancorp lifted its holdings in shares of Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares during the period.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC traded down $0.08 during trading on Friday, reaching $22.77. The stock had a trading volume of 1,666,930 shares, compared to its average volume of 1,718,782. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market cap of $2.10 billion, a PE ratio of 7.47, a P/E/G ratio of 1.46 and a beta of 1.01. The firm's 50 day moving average price is $25.09 and its two-hundred day moving average price is $34.27.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's revenue was up .3% on a year-over-year basis. During the same period in the prior year, the business earned $0.84 EPS. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several research analyst reports. Barclays cut their price objective on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Guggenheim initiated coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective for the company. Finally, Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.